Insta
Govt's Expert Panel Likely To Take Up Applications For Three More COVID-19 Vaccines This Week
Covid-19 vaccine
In what could give a big push to India's ongoing nationwide COVID-19 vaccination drive, the subject expert committee (SEC) of the Central Drugs Standard Organisation (CDSCO) is expected to take up the applications of three different vaccines sometime this week, reports Hindustan Times.
One is the three-dose DNA technology-based COVID-19 vaccine ZyCoV-D developed by Ahmedabad based pharmaceutical major Zydus Cadila. The CDSCO's SEC is likely to take up the application filed the company for an emergency use authorisation.
The other vaccine that is likely to be taken up for consideration is Covovax which is being manufactured by the Pune-based Serum Institute of India (SII). Originally developed by pharmaceutical major Novavax, the said vaccine is presently undergoing trials. However, SII has already begun at-risk advanced manufacturing of the vaccine.
The production of Covovax's first batch at SII had begun in June. The company had meanwhile launched its clinical trials in India in March.
Further, the SEC might also deliberate on the EUA for single-dose Russian COVID-19 vaccine Sputnik Light.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
